期刊文献+

2015年国家评价性抽验复方丹参片的质量分析 被引量:4

Quality Analysis of National Assessment Programs for Compound Danshen Tablets in 2015
下载PDF
导出
摘要 目的根据国家评价性抽验任务,对2015年吉林省全省范围内市场中流通的复方丹参片进行质量分析研究。方法根据《中国药典》2010年版第一增补本及《药品补充检验方法和检验项目批件号2008010》对全省范围内抽检的46批复方丹参片进行了全项检验,并对检验结果进行了统计分析与比较。结果按照现行标准检验,样品合格率为97.8%,但是通过对片剂中樟脑成分的检测发现,各厂家中樟脑的含量差异参差不齐。结论吉林省内抽检的46批样品根据现行检验标准检验,只有1批样品不合格,根据检验依据和结果可以认为,当前吉林省内生产、经营、流通使用的复复方丹参片质量较好。但是发现了不少问题,建议有关部门加强对复方丹参片中冰片投料的监管,以保证产品质量。 Objective According to evaluation of the national drug sampling and testing tasks, circulating in the market Danshen tablets for quality analysis in Jilin Province in 2015. Methods According to Chinese Pharmacopoeia 2010 first supplement and Drug Testing Methods and Complementary Project Approval Document Number 2008010, a province-wide sampling of 46 batches of Salvia tablets were full term tested, and the test results were statistically analyzed and compared. Results Under the current standard test, the sample pass rate was 97.8%, but by the detection of camphor tablets ingredients found differences in the content of the manufac- turers of camphor mixed. Conclusion The 46 batches of samples within a sampling of Jilin Province under the existing test standard test, and only one batch of samples failed. According to test results, and based on the view that the current production of Jilin Province, management, compound Danshen tablets in circulation are of good quality. But we found a lot of problems, and recommend relevant departments to strengthen compound Danshen tablet borneol feeding regulation, to ensure product quality.
作者 杨建龙 韩晶 王辉 徐丹 蔡广知 贡济宇 YANG Jianlong HAN Jing WANG Hui XU Dan CAI Guangzhi GONG Jiyu(Chinese Medicine department Changchun Center for Food and Drug Control, Changchun 130012, China Jilin Institute for Food Control, Changchun 130103, China Drug analysis Laboratories, Changchun University of Chinese Medicine, Changchun 130117, China)
出处 《中国中医药现代远程教育》 2017年第1期139-141,共3页 Chinese Medicine Modern Distance Education of China
关键词 复方丹参片 国家评价性抽验 质量控制 药品管理 compound Danshen tablets evaluation of national drug sample testing quality analysis drug management
  • 相关文献

参考文献3

二级参考文献36

  • 1朱盛山,袁旭江,李苑新.复方丹参缓释片中水溶性成分体外释放度研究[J].中国中药杂志,2006,31(1):37-40. 被引量:23
  • 2魏均娴 唐宝书 王菊芳 等.三七叶皂苷成分的研究.华西药学杂志,1986,1(1):7-7. 被引量:5
  • 3刘灿仿,汶耀琴,王弘,陈世忠.RP-HPLC梯度洗脱法测定心脑贯通滴丸中三七皂苷R_1、人参皂苷Rg_1及人参皂苷Rb_1的含量[J].中成药,2007,29(8):1167-1169. 被引量:16
  • 4.中国药典[S]二部[M].,2005年版.844. 被引量:389
  • 5Hao H,Wang G, Cui N, et al. Pharmacokineties, absorption andtissue distribution of tanshinone II A solid dispersion[J]. Planta Med,2006,72(14):1311-1317. 被引量:1
  • 6Li P, Wang G J, Li J, et al. Characterization of metabolites oftanshinone H A in rats by chromatography/tandem mass spectrometry[J]. J Mass Spectrom, 2006, 41(5):670-684. 被引量:1
  • 7Bi H C, Law F C, Zhong G P, et al. Study of tanshinone II A tissuedistribution in rat by liquid chromatography-tandem mass spec-trometry method[J]. Biomed Chromatogr, 2007,21(5):473-479. 被引量:1
  • 8He T, Zou Q, Feng Z, et al. Study of sodium tanshinone IIA sulfonatetissue distribution in rat by liquid chromatography/tandem massspectrometry [J]. Arzneimittelforschung, 2010,60(11):660-666. 被引量:1
  • 9Li J, Liu P, Liu J P,et al. Novel Tanshinone II A ternary soliddispersion pellets prepared by a single-step technique:In vitro and invivo evaluation[J]. Eur J Pharm Biopharm, 2012, 80(2):426-432. 被引量:1
  • 10Zhang W, He H, Liu J, et al. Pharmacokinetics and atheroscleroticlesions targeting effects of tanshinone II A discoidal and sphericalbiomimetic high density lipoproteins [J]. Biomaterials, 2013,34(1):306-319. 被引量:1

共引文献22

同被引文献47

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部